FLNA Gene Otopalatodigital Syndrome Type 1 NGS Genetic DNA Test
Comprehensive Genetic Testing for Otopalatodigital Syndrome
The FLNA Gene Otopalatodigital Syndrome Type 1 NGS Genetic DNA Test represents a cutting-edge diagnostic tool designed to identify mutations in the FLNA (Filamin A) gene, which is responsible for Otopalatodigital Syndrome Type 1 (OPD1). This rare X-linked genetic disorder affects multiple body systems, primarily involving skeletal development, hearing, and craniofacial structures. Our advanced Next-Generation Sequencing technology provides unparalleled accuracy in detecting genetic variations that contribute to this complex condition.
What Does This Test Measure?
This comprehensive genetic analysis specifically targets the FLNA gene using state-of-the-art NGS methodology to identify:
- Pathogenic mutations in the FLNA gene associated with OPD1
- Single nucleotide variants (SNVs) and small insertions/deletions
- Genetic variations affecting filamin A protein function
- X-linked inheritance patterns characteristic of this disorder
Who Should Consider This Test?
This genetic test is recommended for individuals presenting with clinical features suggestive of Otopalatodigital Syndrome Type 1, including:
- Characteristic skeletal abnormalities such as short stature and digital anomalies
- Hearing impairment or conductive hearing loss
- Cleft palate or other craniofacial abnormalities
- Family history of X-linked skeletal disorders
- Unexplained developmental delays with skeletal involvement
- Individuals with suspected FLNA-related disorders
Key Benefits of FLNA Genetic Testing
- Accurate Diagnosis: Provides definitive confirmation of OPD1 diagnosis
- Family Planning: Enables informed reproductive decisions and genetic counseling
- Personalized Management: Guides appropriate medical interventions and monitoring
- Early Intervention: Facilitates timely treatment for hearing and skeletal issues
- Genetic Counseling: Supports comprehensive family risk assessment
Understanding Your Test Results
Our comprehensive genetic report provides detailed interpretation of your FLNA gene analysis:
- Positive Result: Indicates the presence of a pathogenic FLNA mutation consistent with OPD1 diagnosis
- Negative Result: Suggests that FLNA mutations were not detected, though clinical correlation is essential
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
- Carrier Status: Determines inheritance patterns for family members
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | FLNA Gene Otopalatodigital Syndrome Type 1 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) |
Nationwide Testing Availability
We have branches across the United States, making genetic testing accessible in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our comprehensive network ensures that patients nationwide can access this specialized genetic testing with convenience and reliability.
Take the Next Step Toward Genetic Clarity
If you or your family members are experiencing symptoms suggestive of Otopalatodigital Syndrome Type 1, don’t wait to get answers. Our FLNA genetic test provides the clarity needed for proper diagnosis and management. Contact our genetic specialists today to schedule your test and begin your journey toward understanding your genetic health.
Call or WhatsApp us at +1(267) 388-9828 to book your FLNA Gene Otopalatodigital Syndrome Type 1 NGS Genetic DNA Test today!
